Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure
about
Antitumor effects of galectin-3 inhibition in human renal carcinoma cells.Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives.Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients.Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).Fibrosis and Fibrotic Gene Expression in Pediatric and Adult Patients With Idiopathic Dilated Cardiomyopathy.The prognostic value of sST2 and galectin-3 considering different aetiologies in non-ischaemic heart failure.
P2860
Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure
@ast
Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure
@en
type
label
Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure
@ast
Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure
@en
prefLabel
Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure
@ast
Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure
@en
P2093
P2860
P1476
Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure
@en
P2093
Anupam Basuray
Benjamin French
James C Fang
Jeffrey Brandimarto
Thomas P Cappola
P2860
P304
P356
10.1016/J.CARDFAIL.2015.10.022
P50
P577
2015-11-10T00:00:00Z